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Figure: Imbalance or angiogenic and anti-angiogenic cytokines in OA
cartilage and ChM-1 can protect chondrocytes from inﬂammatory cyto-
Abstracts / Osteoarthritis and Cartilage 22 (2014) S57–S489S132Conclusion: This study places IL18 as an important pathogenic cytokine
in murine OA. The fact that the cytokine is also regulated in the joints of
individuals following acute destabilising knee injuries suggests that it
may have a pathogenic role in driving OA following joint injury and
could be a novel target for disease prevention.
208
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Fundacion Jimenez Diaz, Madrid, Spain; zUniv. Complutense Madrid.
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Purpose: O-linked N-acetylglucosamine (O-GlcNAc) post-translational
modiﬁcations have been implicated in the control of different signaling
cascades and in the development and progression of degenerative and
age-related diseases. We previously showed that accumulation of O-
GlcNAc-modiﬁed proteins alters chondrocyte gene expression, leading
to increased expression of chondrogenic markers in vitro and increased
chondrogenic differentiation in vivo (Andres-Bergos, J Biol Chem 2012).
We also showed that the total amount of O-GlcNAcylated proteins was
signiﬁcantly increased in human osteoarthritic (OA) cartilage compared
to that of healthy cartilage (Tardío, Osteoarthritis Cartilage, in revision).
Here, we aimed to better proﬁle and identify the O-GlcNAc-modiﬁed
proteins in human OA cartilage.
Methods: Human OA cartilage was isolated from patients undergoing
total knee replacement surgery (n ¼ 6), while healthy cartilage was
obtained from age- and gender-matched donors (n ¼ 6). Wheat germ
agglutinin (WGA) chromatography was used to selectively pull-down
O-GlcNAc-modiﬁed proteins. To this end, equal amounts of proteins
isolated from OA and healthy cartilage were loaded on WGA-afﬁnity
columns. The eluted fractions containing O-GlcNAc-modiﬁed proteins
were processed by nano-LC-M/MS, using a 5500QTRAP mass spec-
trometer (AB Sciex), and subsequently analyzed using GeneCodis soft-
ware, which grouped proteins based on predeﬁned biological processes.
Results: Healthy and OA human cartilage shared a number of O-
GlcNAc-modiﬁed proteins; however, ourWGA-based analysis identiﬁed
subsets of proteins O-GlcNAc-modiﬁed differentially in health and
disease. Around a 26% of healthy cartilage speciﬁc proteins were
involved in cytoskeleton organization, and more than 16% play an
important role in cell adhesion. None of these biological processes were
found in the analysis of OA differential proteins suggesting that these
protein modiﬁcations may have an important role in preserving cell
structural integrity in a healthy state. Interestingly, O-GlcNAc mod-
iﬁcations in proteins involved in growth plate cartilage development,
cartilage condensation, or inhibition of angiogenesis were absent in OA
samples and prominent in healthy cartilage. More importantly, O-
GlcNAc modiﬁcations of proteins implicated in extracellular matrix
degradation, cell growth, or complement activation were higher in OA
cartilage than in non-OA/healthy cartilage, clearly separating healthy
and damaged tissue based upon biological processes and subsets of O-
GlcNAc-modiﬁed proteins.
Conclusions: We report here for the ﬁrst time subsets of differentially
O-GlcNAc-modiﬁed proteins in healthy and OA human articular carti-
lage. Biological processes involving O-GlcNAc proteins are different in
OA cartilage in comparison with the healthy one. Our results further
highlight the contribution of this means of protein control to the
development and progression of OA and, more importantly, may con-
tribute to the identiﬁcation of potential biomarkers and/or therapeutic
targets in OA.
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ANTI-ANGIOGENIC FACTORS ARE ESSENTIAL REGULATORS IN
CARTILAGE HOMEOSTASIS AND OSTEOARTHRITIS
X. Zhang, R. Crawford, Y. Xiao. Queensland Univ. of Technology, Brisbane,
Australia
Purpose: Articular cartilage is an avascular tissue by nature, in which
the resident chondrocytes maintain stable phenotype that avoids
hypertrophy and angiogenesis throughout life. It is well known that
physiological response to hypoxia will result in angiogenesis and blood
vessel invasion. However, cartilage under hypoxia can maintainavascular and the abrogation of avascularity in cartilage is related to
several joint diseases such as osteoarthritis (OA). The anti-angiogenic
factors in cartilage homeostasis are far from understanding.
We hypothesize that anti-angiogenic property is essential in main-
taining the physiological functions of chondrocytes and preventing
hypertrophy. Our aim is to clarify whether anti-angiogenic factor is
crucial in chondrocyte maturation and stabilizing chondrocyte pheno-
type, and whether maintenance of anti-angiogenic property (via
chondromodulin-1 (ChM-1) overexpression) could protect chondrocyte
from inﬂammatory cytokine-induced hypertrophy.
Methods: ChM-1 expression during chondrocyte maturation was
investigated in the chondrogenic culture condition of cells derived from
cartilage and bone marrow. Lenti-virus vectors carrying ChM-1 com-
plementary DNA (LV-ChM-1) and ChM-1 siRNA was constructed to
overexpress and downregulate ChM-1. Chondrogenesis (ChM-1, COL2,
ACAN and SOX9) in human articular cartilage chondrocytes (ACCs)
transfected with LV-ChM-1or ChM-1 siRNA was evaluated by qRT-PCR
and westen blot. Human OA cartilage samples were collected and
subjected to gene proﬁling of angiogenic and anti-angiogenic cytokines
using human angiogenesis PCR arrays. Tumor necrosis factor alpha
(TNFa) was applied to mimic the inﬂammatory environment in OA.
ACCs with ChM-1 overexpression or inhibition were exposed to TNFa,
and the chondrogenic and hypertrophic markers (RUNX2, COL10,
MMP13, ALP and VEGF) were investigated by qRT-PCR and western blot.
The MAPK cell signalling pathways were studied to unveil the potential
mechanisms involved in the process.
Results: Imbalanced expression of angiogenic and anti-angiogenic
factors was found in OA cartilage (Figure A). ChM-1 expression was
strongly correlated with the chondrogenesis in cells both from cartilage
and bone marrow. ACCs with ChM-1 overexpression could signiﬁcantly
increase chondrogenic genes (ChM-1, COL2 and ACAN) expression and
decrease hypertrophic markers (RUNX2, COL10, MMP13, ALP and
VEGF); while deceasing ChM-1 by siRNA led to reduced chondrogenesis
and increased hypertrophic marker expression.
The angiogenesis PCR arrays revealed that in OA cartilage, majority
of anti-angiogenic factors showed a decreased trend; while angio-
genic-related cytokines were increased (Figure B). It was found that
ACCs with ChM-1 overexpression could protect chondrocytes from
inﬂammatory cytokine-induced hypertrophy by TNFa (Figure C);
whereas decreasing ChM-1 level by ChM-1 siRNA resulted in the loss
of chondrogenic markers leading to hypertreophy and became more
sensitive to inﬂammatory cytokines (Figure D). It was noted that
ChM-1 suppressed TNFa-induced phosphorylation of ERK-1/2 and
p38 in ACCs.
Conclusions: This study demonstrated that the potent anti-angio-
genic factors, such as ChM-1, are essential in maintaining chon-
drocyte phenotype and avascular status of cartilage. ChM-1 can
protect chondrocytes from inﬂammatory cytokine-induced hyper-
trophy, indicating anti-angiogenesis could be a potential target for
novel therapies of OA.kine-induced hypertrophy. *p < 0.05.
